Size and shape evaluation of astrocytoma nuclei with the shape analytical morphometry software system

Area of Science:

• Neuro-oncology
• Quantitative Pathology
• Biomedical Engineering

Background:

• Astrocytomas are primary brain tumors with varying grades of malignancy.
• Accurate grading is crucial for prognosis and treatment planning.
• Morphological analysis offers potential for objective tumor characterization.

Purpose of the Study:

• To investigate the utility of analytical morphometry in discriminating astrocytoma grades (1-3).
• To assess if nuclear size and shape parameters can differentiate malignancy grades.
• To evaluate the effectiveness of quantitative shape analysis in astrocytoma grading.

Main Methods:

• Studied 18 astrocytoma cases (grades 1-3) using analytical morphometry.
• Calculated nuclear dimensional measurements and shape irregularities.
• Quantified nuclear symmetry using the shape asymmetry evaluator.
• Applied univariate and multivariate statistical analyses to morphometric parameters.

Main Results:

• Morphometric parameters clearly distinguished grade 1 astrocytomas from grades 2 and 3.
• Nuclear size and shape parameters showed significant differences for grade 1.
• Grades 2 and 3 astrocytomas exhibited similar nuclear dimensions and shapes, hindering complete discrimination.

Conclusions:

• Analytical morphometry is a valuable tool for distinguishing low-grade (grade 1) astrocytomas.
• Nuclear morphometric features alone are insufficient to reliably differentiate between grade 2 and grade 3 astrocytomas.
• Further research may be needed to identify additional quantitative markers for higher-grade astrocytoma discrimination.